Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 7/25/2014 7:43:20 AM - Followers: 439 - Board type: Free - Posts Today: 9

Cellceutix Corporation (CTIX) 



Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


Management:   http://cellceutix.com/team/
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
Product Pipeline:  http://cellceutix.com/pipeline/

Recent News and Press Releases: 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure
Investor Relations:  info@cellceutix.com


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant 06/23/2014 07:00:00 AM
CTIX News: Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering Eighth Cohort 06/16/2014 07:00:00 AM
CTIX News: Cellceutix Completes Patient Enrollment in Clinical Trial of Prurisol 06/02/2014 07:00:00 AM
CTIX News: Cellceutix Signs Material Transfer Agreements for Defensin Mimetic Compounds With Leading Universities 05/27/2014 07:00:00 AM
CTIX News: Cellceutix Plans for Entry in Diabetic Foot Wound and Ulcer Market 05/19/2014 07:00:00 AM
#63926  Sticky Note New Blog post from Ellaruth on seeking alpha. jok 07/25/14 02:31:30 AM
#63054  Sticky Note Complete Pre-publish Proof Copy Brilacidin Article BigKahuna 07/07/14 04:03:26 AM
#62804  Sticky Note Research and development grants for the 3 months BooDog 07/02/14 07:15:59 AM
#57289  Sticky Note Cellceutix Initiates Clinical Trial of Prurisol as New starbuxsux 03/25/14 09:02:21 AM
#51541  Sticky Note Very impressive and positive CTIX PR and presentation! TOB 01/15/14 02:41:11 PM
#39163  Sticky Note $CTIX News, SEC filings, FDA trials, misc., and chart: KarinCA 08/25/13 03:20:25 PM
#63933   gotta love the 'skull and bones' bit at EasyRider 07/25/14 07:43:20 AM
#63932   Another great write up, she really has a TheProgressive 07/25/14 07:41:53 AM
#63931   When is Phase 1 on Kevetrin supposed to smitter 07/25/14 07:19:39 AM
#63930   Thanks jok- unfortunately the market is doing a tombrady12nh 07/25/14 06:13:43 AM
#63929   Thanks Jok! Another well written piece by Ellaruth. John B 07/25/14 05:56:45 AM
#63928   :-) Nice. I like it when I BooDog 07/25/14 05:40:40 AM
#63927   Waiting for that wonderful morning...where everything will fall vip1999 07/25/14 03:00:46 AM
#63926   New Blog post from Ellaruth on seeking alpha. jok 07/25/14 02:31:30 AM
#63925   etrade, you are right, CMC is excellent tootalljones 07/25/14 12:46:23 AM
#63924   Non cookie cutter ongoing posts of investors like etradeedge 07/24/14 11:00:28 PM
#63923   The "another one of those drugs" phrasing was BigKahuna 07/24/14 10:44:13 PM
#63922   " B is another one of those drugs eventhelosers 07/24/14 09:33:40 PM
#63921   That scenario is if either of the one BigKahuna 07/24/14 07:47:34 PM
#63920   Great post. August 1st we are 60 days Matagordaville 07/24/14 07:47:02 PM
#63919   I like your scenario even better than BK's noretreat 07/24/14 07:45:20 PM
#63918   That scenario has a lot of appeal. noretreat 07/24/14 07:28:58 PM
#63917   No, I'm sorry, but I don't have a CallMeCrazy 07/24/14 07:26:41 PM
#63916   Crazy...is there a link to this? TheDane 07/24/14 06:25:21 PM
#63915   The Cidin Class: New Kid On The Block CallMeCrazy 07/24/14 05:51:51 PM
#63914   will wait and see Dr Jerry 07/24/14 04:39:51 PM
#63913   What happened to buying on your $1.40 dips ROMAD Diver 07/24/14 03:59:06 PM
#63912   Puma is down 8%... Or did you mean yesterday? EasyRider 07/24/14 03:57:09 PM
#63911   Waiting for another small drop to load up cabel 07/24/14 03:53:56 PM
#63910   Waiting for another small drop to load up Dr Jerry 07/24/14 03:51:52 PM
#63909   Hopefully when comes to partnering its only Brilacidin Whoops 07/24/14 03:45:58 PM
#63908   NR, IMO Aspire-effect. Whoops 07/24/14 03:21:18 PM
#63907   Of course the equivalence and single dose will BigKahuna 07/24/14 03:12:07 PM
#63906   Picked up another 10k shares at $1.65. someconcerns 07/24/14 02:50:22 PM
#63905   bb's are only 9 cents apart, and have noretreat 07/24/14 02:41:45 PM
#63904   Right....and thanks for the reference. Do you noretreat 07/24/14 02:30:53 PM
#63903   Actually Daptomycin resistant strains of MSRAs first began BigKahuna 07/24/14 02:16:31 PM
#63902   not long to wait now after we've already govorchin 07/24/14 01:16:58 PM
#63901   FWIW, bought back in with my base position TheMonolith 07/24/14 01:03:45 PM
#63900   Frustration is definitely setting in here IMO tombrady12nh 07/24/14 12:54:06 PM
#63899   HI NR at 50% of trial they saw govorchin 07/24/14 12:51:38 PM
#63898   Hello Gov- B works, that is for noretreat 07/24/14 12:31:23 PM
#63897   Correctomundo! CallMeCrazy 07/24/14 12:17:27 PM
#63896   Your scenario is indeed possible. I think noretreat 07/24/14 12:00:14 PM
#63895   Resistance has not cropped up yet to any CallMeCrazy 07/24/14 11:37:47 AM
#63894   Move along. Nothing to see here. The site TheDane 07/24/14 11:31:22 AM
#63893   I have extreme confidence in P and B(OM). cabel 07/24/14 11:28:27 AM
#63892   I agree with you again. B would noretreat 07/24/14 11:25:29 AM
#63891   I agree K is something very special. But cabel 07/24/14 11:19:53 AM
#63890   Dose regimen with B is shorter.... Matagordaville 07/24/14 11:17:42 AM
#63889   i thought leo said in an email that govorchin 07/24/14 11:09:56 AM
#63888   I agree. But the deal would not noretreat 07/24/14 11:03:03 AM
#63887   As far as resistance, that issue has not noretreat 07/24/14 11:02:54 AM
#63886   and,... very little side effects! cabel 07/24/14 10:26:27 AM
#63885   You forget lack of resistance... That is HUGE Ultimate01 07/24/14 10:14:59 AM
#63884   f B and D are a Stat Toe cabel 07/24/14 10:11:11 AM